What do GIs need to know about COVID-19? Read the week’s top stories in gastroenterology
Click Here to Manage Email Alerts
The top story in gastroenterology last week was a Q&A with Edward V. Loftus, MD, chief medical editor of Healio Gastroenterology and Liver Disease, who reviewed what gastroenterologists need to know about COVID-19.
Another top story was about the Crohn’s and Colitis Foundation’s new guidelines for patients with inflammatory bowel disease. The guidelines outline how these patients can protect themselves against COVID-19.
Read these and more of last week’s top stories in gastroenterology below:
Q&A: What GIs need to know about COVID-19
As the concern about COVID-19 continues to spread, the entire medical community is on alert. Associations are cancelling or altering plans for scientific conferences, and institutions are implementing travel bans for faculty. Read more.
Crohn’s and Colitis Foundation issues guidance on COVID-19 for patients with IBD
The Crohn’s and Colitis Foundation issued guidelines for patients with IBD to protect themselves from COVID-19 such as talk with their gastroenterologist about medications, their health status and any precautions they should take related to COVID-19. Read more.
FDA issues safety alert for FMT
Two patients died and four were hospitalized after receiving fecal microbiota transplantations from OpenBiome stool donors, according to a safety alert from the FDA and a press release from the company. Read more.
Healthy lifestyle linked with reduced mortality in IBD
Patients who adhere to healthy lifestyle choices, including those related to diet, exercise and smoking habits, had reduced mortality, according to study results. Read more.
Anti-IL-23 therapy effective in treating IBD
Interleukin-23 inhibitors are effective for induction and maintenance of remission in Crohn’s disease and ulcerative colitis, according to an expert at the GUILD Conference 2020. Read more.